Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01219517 · ClinicalTrials.gov registry record · NA
Validation of the Accuracy of DNA Fingerprinting Using Polar Bodies and Embryonic Cells
A NA study, sponsored by Reproductive Medicine Associates of New Jersey.
- Completed
- Registry status
- NA
- Development phase
- 100
- Enrollment target
NCT01219517 is a NA study that has completed, run by Reproductive Medicine Associates of New Jersey. The registered enrollment target is 100 participants.
The verdict
NCT01219517, a NA study, has completed, sponsored by Reproductive Medicine Associates of New Jersey.
- COMPLETED
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
Study Summary
The purpose of this study is to validate the ability to assess the genetic differences (DNA fingerprinting) on polar bodies (excess genetic material given off from the egg) and cells so that this technique may be used in the future to confirm markers of reproductive competence and improve the efficiency and safety of clinical human in vitro fertilization.
Interventions
- OTHER Polar body and embryo biopsy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2008-01 |
| Est. Completion | 2009-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01219517
The ClinicalTrials.gov registry entry for NCT01219517 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Reproductive Medicine Associates of New Jersey, which has 51 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Polar body and embryo biopsy is the first listed.
NCT01219517 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01219517 about?
NCT01219517 is a clinical study titled "Validation of the Accuracy of DNA Fingerprinting Using Polar Bodies and Embryonic Cells". The purpose of this study is to validate the ability to assess the genetic differences (DNA fingerprinting) on polar bodies (excess genetic material given off from the egg) and cells so that this technique may be used in the future to confirm markers of reproductive competence and improve the effici...
What is the current status of trial NCT01219517?
This trial is currently completed. It is a NA study. The enrollment target is 100 participants. The study started on 2008-01. Estimated completion is 2009-12.
What interventions are being tested in trial NCT01219517?
The interventions under investigation include: Polar body and embryo biopsy (OTHER).
Who is sponsoring clinical trial NCT01219517?
This trial is sponsored by Reproductive Medicine Associates of New Jersey, which has 51 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.